{{Rsnum
|rsid=6929404
|Chromosome=6
|position=135132889
|Orientation=plus
|GMAF=0.3012
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 10.5 | 31.6 | 57.9
| HCB | 13.5 | 43.2 | 43.2
| JPT | 11.9 | 33.3 | 54.8
| YRI | 8.9 | 25.0 | 66.1
| ASW | 0.0 | 0.0 | 0.0
| CHB | 13.5 | 43.2 | 43.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{omim
|desc=FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HBFQTL2
|id=142470
|rsnum=6929404
}}

{{PMID Auto
|PMID=17592125
|Title=Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults.
|OA=1
}}

{{PMID Auto
|PMID=18667698
|Title=DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
|OA=1
}}

{{PMID Auto
|PMID=20401335
|Title=Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | Affy GenomeWide 6}}